Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent

January 17, 2026 updated by: Mina Reda Rezk Nada, Cairo University

Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent: Comparative Study

This study aims to compare the effectiveness of "Schroth method" and "Scientific Exercise Approach to Scoliosis" for correcting idiopathic scoliosis in adolescents.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The Schroth Method has gained prominence in the treatment of scoliosis due to its individualized approach, focusing on three-dimensional corrections through specific exercises tailored to each patient's spinal curvature. This method emphasizes rotational breathing and postural awareness, aiming to improve posture, reduce pain, and halt curve progression. Studies have shown that the Schroth Method can effectively improve spinal alignment, reduce curve severity, and enhance overall quality of life in patients with scoliosis. As a non-surgical intervention, it offers a valuable option for patients seeking to manage scoliosis conservatively. In contrast, the Scientific Exercise Approach to Scoliosis (SEAS) is another evidence-based method designed to treat scoliosis. SEAS focus on active self-correction, proprioceptive training, and functional exercises to stabilize and support the spine during daily activities. This approach is grounded in the principles of biomechanics and motor control, with an emphasis on developing the patient's ability to maintain correct posture independently. SEAS has been shown to be effective in reducing the risk of scoliosis progression and in some cases, it may reduce the need for bracing or surgery.

Comparing the Schroth Method and Scientific Exercise Approach to Scoliosis reveals significant insights into their respective benefits and limitations. While both approaches aim to address scoliosis through non-invasive means, they differ in their specific techniques and theoretical foundations. The Schroth Method's emphasis on breathing and postural correction contrasts with SEAS's focus on active self-correction and functional integration. Understanding these differences is crucial for clinicians to tailor treatment plans according to individual patient needs and preferences. This comparative study aims to provide deeper insights into the efficacy of these two approaches, potentially guiding more effective treatment strategies for adolescents with idiopathic scoliosis.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
30

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

  • Name: Maya Galal Abd El Wahab, PhD

Study Locations

  • Egypt
      • Gamasa, Egypt
        • Faculty of Physical Therapy - Delta University for Science and Technology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Teenagers diagnosed with typical idiopathic scoliosis.
  • Teenagers aged 13 to 18 years
  • Both genders will be included.
  • Participants with a Cobb angle ranging from 10° to 25°, as determined by radiographic analysis.
  • Participants with Risser sign of 2 to 3, indicating incomplete skeletal maturity.
  • Participants must be able to understand and follow instructions, ensuring effective participation in the treatment protocol.

Exclusion Criteria:

  • Adolescents with significant visual or auditory impairments that could interfere with the ability to participate in or benefit from the rehabilitation programs.
  • Adolescents with cognitive, mental, or psychological disorders that hinder understanding or following the instructions necessary for the treatment protocol.
  • Adolescents who have previously undergone spinal surgery or any surgical interventions related to scoliosis or other spinal conditions.
  • Adolescents with non-idiopathic scoliosis or scoliosis secondary to other underlying conditions (e.g., neuromuscular, congenital, or syndromic scoliosis).
  • Adolescents with fixed spinal deformities that are not amenable to correction through non-surgical 3D approach.
  • Adolescents with concurrent musculoskeletal conditions that could interfere with the treatment or assessment of scoliosis (e.g., significant hip or knee deformities).
  • Adolescents currently participating in other clinical trials or receiving treatments that might confound the study results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Schroth treatment
Fifteen adolescents will participate in one-hour Schroth treatment sessions, conducted three times per week in center under therapist supervision on non-consecutive days.
Other: Schroth treatment
The exercise program targets three-dimensional spinal correction and includes Schroth breathing for rib cage expansion, pelvic tilts for pelvic alignment, side-shift exercises for lateral correction, rotational angular breathing for derotation, seated rotational stretches for lumbar flexibility, trunk elongation with resistance for postural strength, hanging stretches for spinal decompression, and arm-leg lifts to enhance core stability and coordination.
Experimental: Scientific Exercise Approach to Scoliosis (SEAS)
The home program will consist of fifteen adolescents coming to the center once a month for Scientific Exercise Approach to Scoliosis (SEAS) treatment sessions, each lasting one hour. These sessions will be conducted three days per week, one hour, at home on non-consecutive days.
Other: Scientific Exercise Approach to Scoliosis (SEAS)
The SEAS exercise program emphasizes active self-correction, core stability, and postural control during functional movements. Key exercises include pelvic tilts, seated forward bends, standing side bends, supine marching, bird-dog, heel slides, chest openers, and supine knee-to-chest stretches, all performed with self-correction to maintain neutral spinal alignment, improve muscular control, flexibility, and long-term postural stability.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Cobb Angle
Time Frame: 12 weeks
It will be assessed using standard standing posteroanterior spinal radiographs and will be measured before and after the intervention period. This outcome measure will be used to quantify the magnitude of the lateral spinal curvature and to evaluate changes in spinal alignment, allowing determination of the degree of curve correction or progression following the intervention.
12 weeks
Angle of Trunk Rotation (ATR)
Time Frame: 12 weeks
It will be measured using a scoliometer during the Adam's forward bend test and will be assessed before and after the intervention period. This outcome measure will be used to evaluate the degree of rotational trunk deformity, reflecting the axial component of the three-dimensional spinal deformity in scoliosis.
12 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Risser Sign
Time Frame: 12 weeks
It will be evaluated using pelvic radiographs and will serve as an indicator of skeletal maturity. This outcome measure will be used to estimate remaining growth potential and to assess the risk of scoliosis curve progression during the growth period.
12 weeks
Health-Related Quality of Life (HRQOL)
Time Frame: 12 weeks
It will be assessed using validated Arabic versions of the Scoliosis Research Society-22 (SRS-22) questionnaire or the Pediatric Quality of Life Inventory (PedsQL). These instruments will be used to evaluate multiple domains affected by scoliosis, including pain, functional status, self-image, emotional well-being, and social functioning, providing a comprehensive measure of patients' perceived health and overall quality of life.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cairo University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Khaled Olama, PhD, Professor, Cairo university
  • Study Director: Maya Galal Abd El Wahab, PhD, Ass. Professor, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 15, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 17, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 17, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 26, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 26, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 17, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • P.T.REC/012/005623

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Scoliosis

Clinical Trials on Schroth treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings